Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Clinical trial NCT00629798 · COMPLETED
Trial details
- NCT number
- NCT00629798
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-12
- Primary completion
- 2020-10-20
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.